Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

Overview of attention for article published in Journal of Asthma and Allergy, January 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Blogs Dimensions citations

So far, Dimensions has found 44 publications that cite this research output.

44

The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.

THE AUTHORS RESPOND.

Article in Journal of Managed Care & Specialty Pharmacy (April 2024)

COMMENT ON MODEL INPUTS AND ASSUMPTIONS FOR THE COST-MINIMIZATION MODEL USED TO COMPARE COST OF BIOLOGICS IN SEVERE ASTHMA.

Article in Journal of Managed Care & Specialty Pharmacy (April 2024)

Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review

Article in Cureus (December 2023)